{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:51:16Z","timestamp":1786985476450,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:00:00Z","timestamp":1693008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.brachy.2023.08.006","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T09:14:57Z","timestamp":1695374097000},"page":"840-850","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Conformal 3D computed tomography planned endoluminal brachytherapy for the local control of esophageal cancer"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4513-4964","authenticated-orcid":false,"given":"Christopher M.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1417-387X","authenticated-orcid":false,"given":"Annabel","family":"Lyles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bownes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0718-3941","authenticated-orcid":false,"given":"Rebecca","family":"Goody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4877-5174","authenticated-orcid":false,"given":"Mohan","family":"Hingorani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eldho","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Radhakrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2023.08.006_bib0001","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S2468-1253(20)30007-8","article-title":"The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.brachy.2023.08.006_bib0002","doi-asserted-by":"crossref","first-page":"17048","DOI":"10.1038\/nrdp.2017.48","article-title":"Oesophageal cancer","volume":"3","author":"Smyth","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.brachy.2023.08.006_bib0003","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1200\/JCO.2005.00.034","article-title":"Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus","volume":"23","author":"Stahl","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2023.08.006_bib0004","article-title":"Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer","volume":"8","author":"Vellayappan","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.brachy.2023.08.006_bib0005","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2005.04.7118","article-title":"Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102","volume":"25","author":"Bedenne","year":"2007","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.brachy.2023.08.006_bib0006","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41416-021-01485-9","article-title":"Advances in the curative management of oesophageal cancer","volume":"126","author":"Bolger","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.brachy.2023.08.006_bib0007","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3390\/cancers14020431","article-title":"Modern management of esophageal cancer: Radio-oncology in neoadjuvancy, adjuvancy and palliation","volume":"14","author":"Cellini","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.brachy.2023.08.006_bib0008","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/jamaoncol.2021.0848","article-title":"Efficacy of reduced-intensity chemotherapy with oxaliplatin and capecitabine on quality of life and cancer control among older and frail patients with advanced gastroesophageal cancer: The GO2 phase 3 randomized clinical trial","volume":"7","author":"Hall","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.brachy.2023.08.006_bib0009","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.clon.2019.01.010","article-title":"Hypofractionated radiotherapy in oesophageal cancer for patients unfit for systemic therapy: A retrospective single-centre analysis","volume":"31","author":"Jones","year":"2019","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.brachy.2023.08.006_bib0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.7150\/jca.13655","article-title":"Survival and symptom relief after palliative radiotherapy for esophageal cancer","volume":"7","author":"Welsch","year":"2016","journal-title":"J Cancer"},{"key":"10.1016\/j.brachy.2023.08.006_bib0011","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1470-2045(13)70136-0","article-title":"Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2\/3 randomised trial","volume":"14","author":"Crosby","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2023.08.006_bib0012","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejca.2016.11.031","article-title":"NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin\/capecitabine or carboplatin\/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma","volume":"74","author":"Mukherjee","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.brachy.2023.08.006_bib0013","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/bjc.2017.21","article-title":"Long-term results and recurrence patterns from SCOPE-1: A phase II\/III randomised trial of definitive chemoradiotherapy +\/- cetuximab in oesophageal cancer","volume":"116","author":"Crosby","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.brachy.2023.08.006_bib0014","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1001\/jama.281.17.1623","article-title":"Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group","volume":"281","author":"Cooper","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.brachy.2023.08.006_bib0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2020-000492","article-title":"Single modality radical radiotherapy is an acceptable alternative for the older patient with squamous cell carcinoma of the oesophagus","volume":"8","author":"Derby","year":"2021","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.brachy.2023.08.006_bib0016","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005048.pub2","article-title":"Interventions for dysphagia in oesophageal cancer","author":"Sreedharan","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.brachy.2023.08.006_bib0017","unstructured":"Matera K, Kowalik T, Lyczek J. Comparison of 2D and 3D planning in HDR brachytherapy in oesophageal cancer, with consideration of isodose distribution in PTV and OAR. Ann Med Biomed Sci 4, 14\u201318."},{"key":"10.1016\/j.brachy.2023.08.006_bib0018","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.brachy.2020.09.006","article-title":"Evaluation of a collapsed-cone convolution algorithm for esophagus and surface mold 192Ir brachytherapy treatment planning","volume":"20","author":"Eason","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.08.006_bib0019","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/j.clon.2019.03.045","article-title":"Brachytherapy in the palliation of oesophageal cancer: Effective but impractical?","volume":"31","author":"Sinha","year":"2019","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.brachy.2023.08.006_bib0020","doi-asserted-by":"crossref","first-page":"PS15","DOI":"10.1016\/j.clon.2011.01.348","article-title":"Single centre experience using 3D CT conformal planning for patients treated with intraluminal brachytherapy in oesophageal cancer","volume":"23","author":"Radhakrishna","year":"2011","journal-title":"Clin Oncol"},{"key":"10.1016\/j.brachy.2023.08.006_bib0021","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0140-6736(04)17272-3","article-title":"Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: Multicentre randomised trial","volume":"364","author":"Homs","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2023.08.006_bib0022","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1442-2050.2005.00467.x","article-title":"Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial","volume":"18","author":"Bergquist","year":"2005","journal-title":"Dis Esophagus"},{"issue":"3","key":"10.1016\/j.brachy.2023.08.006_bib0023","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.radonc.2013.04.008","article-title":"Palliative brachytherapy with or without primary stent placement in patients with oesophageal cancer, a randomised phase III trial","volume":"107","author":"Amdal","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2023.08.006_bib0024","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S1470-2045(14)70131-7","article-title":"Conventional stents versus stents loaded with (125)iodine seeds for the treatment of unresectable oesophageal cancer: A multicentre, randomised phase 3 trial","volume":"15","author":"Zhu","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2023.08.006_bib0025","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.brachy.2004.09.004","article-title":"Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer","volume":"3","author":"Sur","year":"2004","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.08.006_bib0026","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.radonc.2010.09.001","article-title":"Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: A prospective multi-centre randomized trial of the International Atomic Energy Agency","volume":"97","author":"Rosenblatt","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2023.08.006_bib0027","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1245\/s10434-018-6365-1","article-title":"Salvage surgery for esophageal cancer: How to improve outcomes?","volume":"25","author":"Cohen","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.brachy.2023.08.006_bib0028","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.brachy.2015.02.392","article-title":"Salvage high-dose-rate brachytherapy for esophageal cancer in previously irradiated patients: A retrospective analysis","volume":"14","author":"Kam","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.08.006_bib0029","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.brachy.2020.04.002","article-title":"Esophageal brachytherapy: Institut Gustave Roussy's experience","volume":"19","author":"Kissel","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.08.006_bib0030","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.brachy.2018.01.010","article-title":"Endoluminal high-dose-rate brachytherapy for locally recurrent or persistent esophageal cancer","volume":"17","author":"Taggar","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.08.006_bib0031","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<988::AID-CNCR7>3.0.CO;2-U","article-title":"A phase I\/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): Final report","volume":"88","author":"Gaspar","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2023.08.006_bib0032","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1200\/JCO.2002.20.5.1167","article-title":"INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy","volume":"20","author":"Minsky","year":"2002","journal-title":"J. Clin. Oncol."}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472123016252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472123016252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:19:48Z","timestamp":1761531588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472123016252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1538472123016252"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2023.08.006","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conformal 3D computed tomography planned endoluminal brachytherapy for the local control of esophageal cancer","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2023.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of American Brachytherapy Society.","name":"copyright","label":"Copyright"}]}}